TradingView
RocketTickers
Dec 21, 2020 6:03 PM

Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), Long

NYSE:MYOV60

Description

⋅
MYOV: Myovant Sciences, Inc.
2020-12-18 16:49:37
Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer
Beyond Technical Analysis
More